Oncology Sponsored Oncology in the NHS: Situations, challenges, and solutions Oncology is a singularly complex healthcare area.
Views & Analysis The changing frontline: how to engage with England’s NHS in ... Wilmington Healthcare-pharmaphorum conference: England’s NHS is moving towards integrated care, and long-term outcomes-based contracts for medicines could become the norm
Views & Analysis Manchester setting the pace in NHS move to outcomes-based de... The NHS is moving rapidly towards integrated care models – and outcomes-based deals with pharma will also play a role.
Views & Analysis The NHS, new models of care and STPs: what role for pharma? These are challenging times in the NHS, with reforms and budget restrictions putting the health service under huge strain.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
